A new analysis of 11 global studies shows that people tend to regain lost weight after stopping anti-obesity medications like ...

Ozempic (semaglutide) and other GLP-1 medications have helped many people lose weight and manage chronic conditions like type ...

GLP-1s (glucagon-like peptide-1 receptor agonists), like Wegovy, Ozempic, or generic liraglutide, have helped you reach your ...

The Trump administration has pledged to curb rising obesity with school meal reforms and artificial dye bans, though the ...

The appetite-suppressing medications reduce consumption of processed and sugary foods, creating new risks and opportunities.

The macronutrient has undergone a women’s health glow-up—but getting enough of it has started to feel like a part-time job ...

A major new study has shown that a group of drugs called GLP-1 receptor agonists offer strong protection for both the kidneys ...

We are nearing a point of no return for GLP-1 drugs. More than one in 10 Americans have already taken a GLP-1 agonist, be it ...

Meshel Laurie has got candid about her whopping 60kg weight loss as she called for a controversial obesity medication to be added to the Pharmaceutical Benefits Scheme (PBS).

A YOUNG woman has revealed that in 14 weeks, she has lost three stone on Mounjaro. But although Jess now feels “healthier” ...

Explore the potential of GLP-1 receptor agonists for rheumatoid arthritis. Learn about their safety, benefits, and what to consider before starting these medications.

New research has revealed that people taking weight loss drugs like Wegovy and Mounjaro are increasingly more likely to ...